USD 0.75 Billion
Report ID: SQSG35G2011 | Region: Global | Published Date: October, 2022 | Pages: 165 | Tables: 62 | Figures: 70
The Global Influenza Diagnostics Market size was valued at USD 0.75 Billion in 2021, and it is expected to reach a value of USD 1.2 Billion by 2028, at a CAGR of 6.89% over the forecast period (2022 - 2028).
Influenza is simply referred to as the flu. It is an infectious disease of the upper respiratory tract caused by the influenza virus. The seasonal influenza virus is classified into three types: Influenza B, Influenza A, And Influenza C, which are characterized by two major surface proteins: hemagglutinin (HA) and neuraminidase (NA). Different serotypes are observed as a result of differences in these surface proteins, which determine the antibody response to the viruses. Because influenza is a highly contagious and communicable disease, infected patients who serve as carriers of the disease can easily transmit the disease in public places.
The disease burden varies by region, with temperate climate regions experiencing seasonal influenza outbreaks. In tropical regions where influenza occurs all year, causing constant outbreaks, disease management and treatment are difficult. Rising demand for rapid disease diagnosis, rising influenza prevalence, and increased influenza research for diagnostic technologies are driving the Influenza Diagnostics Market growth.
Global Market Size
USD 0.75 Billion
Traditional Diagnostic Test
Traditional Diagnostic Test
To get more reports on the above market click here to Buy The Report
The Global Influenza Diagnostics Market is segmented based on Test Type, End-User, and Region. Based on Test Type it is categorized into Traditional Diagnostic Test and Molecular Diagnostic Assay. The Traditional Diagnostic Test segment is further bifurcated into RIDT, Viral Culture, Direct Fluorescent Antibody (DFA) Test, and Serological Assay. Molecular Diagnostic Assay is sub-segmented into RT-PCR, Nucleic Acid Sequence-based Amplification (NASBA) Test, Loop-mediated Isothermal Amplification-based Assay (LAMP), Simple Amplification-based Assay (SAMBA), and Other Molecular Diagnostic Assays. By End User, the Influenza Diagnostics Market studied is segmented into hospitals, Laboratories, and Other End Users. Based on the region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.
Analysis by Test Type
In 2022, the rapid influenza diagnostic test (RIDT) is anticipated to hold the largest market share in the test type segment of the influenza diagnostics market, out of all traditional diagnostic tests. Rapid influenza diagnostic tests (RIDTs) are immunoassays that detect and provide qualitative results for influenza A and B viral nucleoprotein antigens in respiratory specimens. It is capable of diagnosing patients with influenza-like illness, particularly if performed within the first four days of symptoms appearing. RIDT's popularity is driven by the benefits of faster results and ease of use. Some RIDTs are also approved for use in the office or at the patient's bedside. The RIDT segment is also expected to grow rapidly due to its widespread use in point-of-care settings.
Analysis by End-user
The diagnostic laboratories segment dominated the influenza diagnostics market in 2021. The rising prevalence of influenza, as well as the growing demand for rapid disease diagnosis, are driving the growth of this segment
To get detailed analysis on other segments, Request For Sample Report
In 2021, North America dominated the influenza diagnostics market and it is expected to maintain its dominance throughout the forecast period (2022-2028). The regional Influenza Diagnostics Market is expected to be driven by the high prevalence of influenza during the forecast period. It is estimated that, approximately 5% to 20% of Americans will be diagnosed with influenza each year in 2022. Moreover, the Centers for Disease Control and Prevention reported 35 million flu-related illnesses, 380,000 flu-related hospitalizations, 20,000 flu-related deaths, and 16 million flu-related medical visits in 2019-2020. This rising disease burden is believed to have a positive impact on market growth in the coming years. RIDTs are widely available all across the region. The short time required to generate results is the reason for the test's wider availability. RIDT can produce results in as little as 15 minutes. With rising influenza-related hospitalizations and pediatric deaths, as well as government organizations' desire to better manage the disease, the North American influenza diagnostics market is expected to expand in the coming years.
Furthermore, the Asia Pacific region is expected to grow at a rapid pace. Adoption of new technology and increased public awareness are expected to be the factors propelling the market growth. Human infection with avian influenza A (H5NI), which resulted in an influenza pandemic, is one of the most concerning aspects of influenza in Asia. There is a growing concern, and countries are actively involved in taking preventive measures to combat the disease's spread.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report
The Influenza Diagnostics Market is highly competitive, with the existence of numerous major firms operating in both domestic and international markets. The industry's top players are embracing strategic collaboration initiatives to improve market share and profitability. Some of the major players in the market are Becton Dickinson, Biomerieux, Merck, and Bio-Rad Laboratories among others who are driving the Influenza Diagnostics Market.
Top Player’s Company Profiles
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analysis, the increasing prevalence of influenza and related chronic diseases, increased research and development activities in influenza diagnostics technologies, growing awareness for early detection using specific diagnostic tests, and other factors are driving the Global Influenza Diagnostics Market. However, the rising cost of influenza diagnostic kits and reagents is the primary impediment to Influenza Diagnostics Market growth. Furthermore, variability in sensitivity and specificity among influenza diagnostic tests, as well as the presence of a complex regulatory framework for the approval of new diagnostic tests, are expected to limit market growth to some extent.
|Market size value in 2021||USD 0.75 Billion|
|Market size value in 2028||USD 1.2 Billion|
|Forecast period||2022 - 2028|
|Forecast Unit (Value)||USD Billion|
|Regions covered||North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)|
Free report customization with purchase. Customization includes:-
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Parent Market Analysis
KEY MARKET INSIGHTS
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Global Influenza Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Influenza Diagnostics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Influenza Diagnostics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Influenza Diagnostics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.SPEAK TO AN ANALYST
Get lifetime access to our reportsBasic Plan $5,000 Team Plan $10,000 SUBSCRIBE NOW
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "
- Mr. Ali Zali, Commercial Director, ICIIC Iran.
Product ID: SQSG35G2011